Overview
Andrew Branagan is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Branagan has been practicing medicine for over 16 years is highly rated in 5 conditions, according to our data. His top areas of expertise are Waldenstrom Macroglobulinemia, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, and Bone Marrow Aspiration. Dr. Branagan is currently accepting new patients.
His clinical research consists of co-authoring 53 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
55 Fruit St, Boston, MA 02114
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Dana-Farber Cancer Institute, Inc.
David Reardon is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Reardon is highly rated in 22 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Tissue Biopsy. Dr. Reardon is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Philippe Armand is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Armand is highly rated in 29 conditions, according to our data. His top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, and Bone Marrow Transplant. Dr. Armand is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Caron Jacobson is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Jacobson is highly rated in 25 conditions, according to our data. Her top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Jacobson is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Waldenstrom MacroglobulinemiaDr. Branagan isElite. Learn about Waldenstrom Macroglobulinemia.
- Distinguished
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Branagan isDistinguished. Learn about Multiple Myeloma.
- Schnitzler SyndromeDr. Branagan isDistinguished. Learn about Schnitzler Syndrome.
- Advanced
- Smoldering Multiple MyelomaDr. Branagan isAdvanced. Learn about Smoldering Multiple Myeloma.
- Experienced
- AgranulocytosisDr. Branagan isExperienced. Learn about Agranulocytosis.
- B-Cell LymphomaDr. Branagan isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationDr. Branagan isExperienced. Learn about Bone Marrow Aspiration.
- Childhood Iron Deficiency AnemiaDr. Branagan isExperienced. Learn about Childhood Iron Deficiency Anemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Branagan isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Branagan isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
